Fortrea Holdings Inc. (NASDAQ:FTRE) — Market Cap & Net Worth
Market Cap & Net Worth: Fortrea Holdings Inc. (FTRE)
Fortrea Holdings Inc. (NASDAQ:FTRE) has a market capitalization of $948.95 Million ($948.95 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9334 globally and #2551 in its home market, demonstrating a 3.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fortrea Holdings Inc.'s stock price $16.63 by its total outstanding shares 92400000 (92.40 Million). Review Fortrea Holdings Inc. (FTRE) total liabilities to assess the company's total debt and financial obligations.
Fortrea Holdings Inc. Market Cap History: 2023 to 2026
Fortrea Holdings Inc.'s market capitalization history from 2023 to 2026. Data shows change from $3.22 Billion to $1.54 Billion (-17.94% CAGR).
Index Memberships
Fortrea Holdings Inc. is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.04% | #256 of 976 |
|
NASDAQ Composite
IXIC
|
$41.39 Trillion | 0.00% | #971 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.70 Trillion | 0.06% | #147 of 263 |
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.04% | #477 of 602 |
Weight: Fortrea Holdings Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fortrea Holdings Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fortrea Holdings Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.64x
Fortrea Holdings Inc.'s market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $3.22 Billion | $2.84 Billion | -$25.20 Million | 1.13x | N/A |
| 2024 | $1.72 Billion | $2.70 Billion | -$328.50 Million | 0.64x | N/A |
Competitor Companies of FTRE by Market Capitalization
Companies near Fortrea Holdings Inc. in the global market cap rankings as of June 17, 2026.
Key companies related to Fortrea Holdings Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #443 globally with a market cap of $63.36 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $450.46 |
| #443 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.36 Billion | $614.98 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €259.20 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €761.20 |
Fortrea Holdings Inc. Historical Marketcap From 2023 to 2026
Between 2023 and today, Fortrea Holdings Inc.'s market cap moved from $3.22 Billion to $ 1.54 Billion, with a yearly change of -17.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.54 Billion | -3.59% |
| 2025 | $1.59 Billion | -7.51% |
| 2024 | $1.72 Billion | -46.56% |
| 2023 | $3.22 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Fortrea Holdings Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $948.95 Million USD |
| MoneyControl | $948.95 Million USD |
| MarketWatch | $948.95 Million USD |
| marketcap.company | $948.95 Million USD |
| Reuters | $948.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include f… Read more